Follow
Richard A Wells
Richard A Wells
Unknown affiliation
Verified email at sunnybrook.ca
Title
Cited by
Cited by
Year
Identification of miR-145 and miR-146a as mediators of the 5q–syndrome phenotype
DT Starczynowski, F Kuchenbauer, B Argiropoulos, S Sung, R Morin, ...
Nature medicine 16 (1), 49-58, 2010
8122010
Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo
C Yu, AB Cantor, H Yang, C Browne, RA Wells, Y Fujiwara, SH Orkin
The Journal of experimental medicine 195 (11), 1387-1395, 2002
7122002
Improved telomere detection using a telomere repeat probe (TTAGGG) n generated by PCR.
JW Ijdo, RA Wells, A Baldini, ST Reeders
Nucleic acids research 19 (17), 4780, 1991
6611991
Origin of human chromosome 2: an ancestral telomere-telomere fusion.
JW Ijdo, A Baldini, DC Ward, ST Reeders, RA Wells
Proceedings of the National Academy of Sciences 88 (20), 9051-9055, 1991
4711991
Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia
RA Wells, C Catzavelos, S Kamel-Reid
Nature genetics 17 (1), 109-113, 1997
3481997
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study
AG Kulasekararaj, A Hill, ST Rottinghaus, S Langemeijer, R Wells, ...
Blood, The Journal of the American Society of Hematology 133 (6), 540-549, 2019
3012019
GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages
H Iwasaki, S Mizuno, RA Wells, AB Cantor, S Watanabe, K Akashi
Immunity 19 (3), 451-462, 2003
2542003
Tet2 restrains inflammatory gene expression in macrophages
AH Cull, B Snetsinger, R Buckstein, RA Wells, MJ Rauh
Experimental hematology 55, 56-70. e13, 2017
2402017
Hypervariable minisatellites: recombinators or innocent bystanders?
AP Jarman, RA Wells
Trends in Genetics 5, 367-371, 1989
1791989
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells
BZ Carter, M Gronda, Z Wang, K Welsh, C Pinilla, M Andreeff, ...
Blood 105 (10), 4043-4050, 2005
1732005
An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis
SO Abegunde, R Buckstein, RA Wells, MJ Rauh
Experimental hematology 59, 60-65, 2018
1702018
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study
G Garcia-Manero, EA Griffiths, DP Steensma, GJ Roboz, R Wells, ...
Blood, The Journal of the American Society of Hematology 136 (6), 674-683, 2020
1652020
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer …
M Crump, D Hedley, S Kamel-Reid, B Leber, R Wells, J Brandwein, ...
Leukemia & lymphoma 51 (2), 252-260, 2010
1122010
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes
A Giagounidis, P Fenaux, GJ Mufti, P Muus, U Platzbecker, G Sanz, ...
Annals of hematology 87, 345-352, 2008
932008
Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology
P Disperati, CV Ichim, D Tkachuk, K Chun, AC Schuh, RA Wells
Leukemia research 30 (2), 233-239, 2006
912006
Disease biology rather than age is the most important determinant of survival of patients≥ 60 years with acute myeloid leukemia treated with uniform intensive therapy
V Gupta, K Chun, QL Yi, M Minden, A Schuh, R Wells, J Brandwein
Cancer: Interdisciplinary International Journal of the American Cancer …, 2005
912005
Telomere-related sequences at interstitial sites in the human genome
RA Wells, GG Germino, S Krishna, VJ Buckle, ST Reeders
Genomics 8 (4), 699-704, 1990
891990
A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation.
RA Wells, JL Hummel, A De Koven, A Zipursky, M Kirby, I Dube, ...
Leukemia 10 (4), 735-740, 1996
881996
Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study
R Buckstein, RA Wells, N Zhu, HA Leitch, TJ Nevill, KWL Yee, B Leber, ...
British journal of haematology 174 (1), 88-101, 2016
872016
Iron overload in myelodysplastic syndromes: a Canadian consensus guideline
RA Wells, B Leber, R Buckstein, JH Lipton, W Hasegawa, K Grewal, ...
Leukemia research 32 (9), 1338-1353, 2008
812008
The system can't perform the operation now. Try again later.
Articles 1–20